Perioperative Chemotherapy With Low-Dose Radiotherapy and Tislelizumab for Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT07408609 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07408609
- Sponsor
- Jiangsu Cancer Institute & Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-26
- Primary completion
- 2029-02-20
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.